Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 2
2017 1
2018 4
2019 1
2020 3
2021 1
2022 3
2023 2
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean delettre c (52 results)?
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.
Rossi C, Manson G, Marouf A, Cabannes-Hamy A, Nicolas-Virelizier E, Maerevoet M, Alcantara M, Molina L, Ceraulo A, Poirée M, Galtier J, Diop N, Delette C, Segot A, Dubois S, Waultier A, Bernard S, Noël R, Guidez S, Kohn M, Bailly S, Moatti H, Touati M, Renaud L, Kanoun S, Cottereau AS, Kirova Y, Peignaux K, Dourthe ME, Simonin M, Leblanc T, Quéro L, Krzisch D, Duléry R, Grenier A, Gastinne T, Casasnovas O, Gallamini A, André M, Morschhauser F, Deau B, Fornecker LM, Ghesquières H. Rossi C, et al. Among authors: delette c. Eur J Cancer. 2024 Dec;213:115073. doi: 10.1016/j.ejca.2024.115073. Epub 2024 Oct 22. Eur J Cancer. 2024. PMID: 39509848 Free article. Review.
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study.
Tournilhac O, Bouabdallah K, Lecolant S, Hacini M, Laribi K, Bailly S, Belmondo T, Maerevoet MMF, Ysebaert L, Guidez S, Le Gouill S, Bonnet C, Andre M, Dupuis J, Thieblemont C, Bachy E, Daguindau N, Morschhauser F, Tricot S, Moulin C, Banos A, Houot R, Chauchet A, Gyan E, Cartron G, Farhat H, Camus V, Drenou B, Zerazhi H, Sibon D, Nicolas Virelizier E, Delette C, Snauwaert S, Bailly S, Delarue R, Carras S, Ledoux-Pilon A, Parrens M, Griolet S, Gaulard P, Delfau-Larue MH, de Leval LL, Damaj GL. Tournilhac O, et al. Among authors: delette c. Blood Adv. 2025 Aug 4:bloodadvances.2024015787. doi: 10.1182/bloodadvances.2024015787. Online ahead of print. Blood Adv. 2025. PMID: 40758949
Flow cytometry as a fast, cost-effective tool to assess IGHV mutational status in CLL.
Couillez G, Morel P, Clichet V, Fourdrain L, Delette C, Harrivel V, Gubler B, Rottier C, Derreumaux S, Margat E, Garcon L, Marolleau JP, Boyer T. Couillez G, et al. Among authors: delette c. Blood Adv. 2023 Sep 12;7(17):4701-4704. doi: 10.1182/bloodadvances.2022008033. Blood Adv. 2023. PMID: 36287221 Free PMC article. No abstract available.
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma.
Bouard L, Tessoulin B, Thieblemont C, Bouabdallah K, Gastinne T, Oberic L, Carras S, Delette C, Casasnovas O, Dartigeas C, Cacheux V, Masse S, Hermine O, Le Gouill S. Bouard L, et al. Among authors: delette c. Haematologica. 2022 Sep 1;107(9):2163-2172. doi: 10.3324/haematol.2021.279561. Haematologica. 2022. PMID: 35172560 Free PMC article.
Onsets of progression and second treatment determine survival of patients with symptomatic Waldenström macroglobulinemia.
Guidez S, Labreuche J, Drumez E, Ysebaert L, Bakala J, Delette C, Hivert B, Protin C, Declercq H, Verlay M, Marolleau JP, Duhamel A, Morel P; French Innovative Leukemia Organization (FILO) CLL group. Guidez S, et al. Among authors: delette c. Blood Adv. 2018 Nov 27;2(22):3102-3111. doi: 10.1182/bloodadvances.2018021287. Blood Adv. 2018. PMID: 30455359 Free PMC article.
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study.
Pénichoux J, Lanic H, Thill C, Ménard AL, Camus V, Stamatoullas A, Lemasle E, Leprêtre S, Lenain P, Contentin N, Kraut-Tauzia J, Fruchart C, Kammoun L, Damaj G, Farge A, Delette C, Modzelewski R, Vaudaux S, Pépin LF, Tilly H, Jardin F. Pénichoux J, et al. Among authors: delette c. Ann Hematol. 2023 Jul;102(7):1811-1823. doi: 10.1007/s00277-023-05200-x. Epub 2023 Apr 14. Ann Hematol. 2023. PMID: 37058153 Free PMC article.
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study.
Costes-Tertrais D, Hueso T, Gastinne T, Thieblemont C, Oberic L, Bouabdallah K, Garciaz S, Tchernonog E, Dartigeas C, Ribrag V, Fogarty P, Casasnovas RO, Houot R, Delette C, Malak S, Fornecker LM, Gressin R, Damaj G, Le Gouill S. Costes-Tertrais D, et al. Among authors: delette c. Bone Marrow Transplant. 2022 Apr;57(4):627-632. doi: 10.1038/s41409-022-01596-8. Epub 2022 Feb 11. Bone Marrow Transplant. 2022. PMID: 35149851
Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas.
Montes L, Choquet S, Uzunov M, Morel V, Baron M, Roos-Weil D, Joris M, Delette C, Lebon D, Azar N, Metz C, Nichelli L, Le Garff-Tavernier M, Boccon-Gibod C, Lacan C, Souchet L, Hoang-Xuan K, Soussain C, Boussen I, Houillier C. Montes L, et al. Among authors: delette c. Br J Haematol. 2025 Aug 31. doi: 10.1111/bjh.70132. Online ahead of print. Br J Haematol. 2025. PMID: 40887743 No abstract available.
22 results